Andrea Gangfuß

Dr. Andrea Gangfuß

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PMPayam Mohassel
Payam Mohassel
SDSandra Donkervoort
Sandra Donkervoort
MLMuseer A. Lone
Museer A. Lone
MNMatthew Nalls
Matthew Nalls
KGKenneth Gable
Kenneth Gable
CBCarsten G. Bönnemann
Carsten G. Bönnemann

29 May 2022 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
AGAndrea Gangfuß
Andrea Gangfuß
AHAndreas Hentschel
Andreas Hentschel
LHLorena Heil
Lorena Heil
MGMaria Gonzalez
Maria Gonzalez
ASAnne Schönecker
Anne Schönecker
ASAnne Schänzer
Anne Schänzer

11 January 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
AGAndrea Gangfuß
Andrea Gangfuß
GYGökhan Yigit
Gökhan Yigit
JAJanine Altmüller
Janine Altmüller
PNPeter Nürnberg
Peter Nürnberg
JCJohanna Christina Czeschik
Johanna Christina Czeschik
AKAlma Kuechler
Alma Kuechler
Intellectual disability (ID) has an estimated prevalence of 1.5%–2%. Whole exome sequencing (WES) studies have identified a multitude of novel causative gene defects and have shown that sporadic ID cases result from de novo mutations in genes associated with ID. Here, we report on a 10‐year‐old girl, who has been regularly presented in our neuropediatric and genetic outpatient clinic. A median cleft palate and a heart defect were surgically corrected in infancy. Apart from ID, she has behavioral anomalies, muscular hypotonia, scoliosis, and hypermobile joints. The facial phenotype is characterized by arched eyebrows, mildly upslanting long palpebral fissures, prominent nasal tip, and large, protruding ears. Trio WES revealed a de novo missense variant in MEIS2 (c.998G>A; p.Arg333Lys). Haploinsufficiency of MEIS2 had been discussed as the most likely mechanism of the microdeletion 5q14‐associated complex phenotype with ID, cleft palate, and heart defect. Recently, four studies including in total 17 individuals with intragenic MEIS2 variants were reported. Here we present the evolution of the clinical phenotype and compare with the data of known individuals.

13 October 2020 in Journal of Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
AGAndrea Gangfuß
Andrea Gangfuß
DSDirk Schmitt
Dirk Schmitt
ARAndreas Roos
Andreas Roos
FBFrederik Braun
Frederik Braun
MAMelanie Annoussamy
Melanie Annoussamy
USUlrike Schara-Schmidt
Ulrike Schara-Schmidt
X-linked myotubular myopathy (XLMTM) is a life-threatening rare neuromuscular disease, which is caused by pathogenic variants in the MTM1 gene. It has a large phenotypic heterogeneity, ranging from patients, who are able to walk independently to immobile patients who are only able to bring hand to mouth and depend on a respirator 24 hours a day every day. This suggests that ventilator requirements may not illustrate the full clinical picture of patients with XLMTM. At present, there is no curative therapy available, despite first promising results from ongoing gene therapy studies. In this study, we evaluated in detail the data from 13 German XLMTM patients, which was collected over a period of up to 20 years in our university hospital. We compared it to the international prospective longitudinal natural history study (NHS) data from 45 patients (containing 11 German patients). To highlight the broad phenotypic spectrum of the disease, we additionally focused on the clinical presentation of three cases at a glance. Comparing our data with the above mentioned natural history study, it appears the patients of the present German cohort seem to be more often severely affected, with higher frequency of non-ambulatory patients and patients on ventilation (and for longer time) and a higher proportion of patients needing a percutaneous endoscopic gastrostomy. Another key finding is a potential gap in time between first clinical presentation and final diagnosis, showing a need for patients to be treated in a specialized center for neuromuscular diseases.

2 October 2021 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
AGAndrea Gangfuß
Andrea Gangfuß
ACArtur Czech
Artur Czech
AHAndreas Hentschel
Andreas Hentschel
UMUte Münchberg
Ute Münchberg
RHRita Horvath
Rita Horvath
ARAndreas Roos
Andreas Roos
Recessive variants in WASHC4 are linked to intellectual disability complicated by poor language skills, short stature, and dysmorphic features. The protein encoded by WASHC4 is part of the Wiskott–Aldrich syndrome protein and SCAR homolog family, co‐localizes with actin in cells, and promotes Arp2/3‐dependent actin polymerization in vitro. Functional studies in a zebrafish model suggested that WASHC4 knockdown may also affect skeletal muscles by perturbing protein clearance. However, skeletal muscle involvement has not been reported so far in patients, and precise biochemical studies allowing a deeper understanding of the molecular etiology of the disease are still lacking. Here, we report two siblings with a homozygous WASHC4 variant expanding the clinical spectrum of the disease and provide a phenotypical comparison with cases reported in the literature. Proteomic profiling of fibroblasts of the WASHC4‐deficient patient revealed dysregulation of proteins relevant for the maintenance of the neuromuscular axis. Immunostaining on a muscle biopsy derived from the same patient confirmed dysregulation of proteins relevant for proper muscle function, thus highlighting an affliction of muscle cells upon loss of functional WASHC4. The results of histological and coherent anti‐Stokes Raman scattering microscopic studies support the concept of a functional role of the WASHC4 protein in humans by altering protein processing and clearance. The proteomic analysis confirmed key molecular players in vitro and highlighted, for the first time, the involvement of skeletal muscle in patients. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

20 February 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SGSarah Christina Goretzki
Sarah Christina Goretzki
MBMaire Brasseler
Maire Brasseler
BDBurcin Dogan
Burcin Dogan
THTom Hühne
Tom Hühne
DBDaniel Bernard
Daniel Bernard
NBNora Bruns
Nora Bruns
Background: Long COVID (LC) is a diagnosis that requires exclusion of alternative somatic and mental diseases. The aim of this study was to examine the prevalence of differential diagnoses in suspected pediatric LC patients and assess whether adult LC symptom clusters are applicable to pediatric patients. Materials and Methods: Pediatric presentations at the Pediatric Infectious Diseases Department of the University Hospital Essen (Germany) were assessed retrospectively. The correlation of initial symptoms and final diagnoses (LC versus other diseases or unclarified) was assessed. The sensitivity, specificity, negative and positive predictive values of adult LC symptom clusters were calculated. Results: Of 110 patients, 32 (29%) suffered from LC, 52 (47%) were diagnosed with alternative somatic/mental diseases, and 26 (23%) remained unclarified. Combined neurological and respiratory clusters displayed a sensitivity of 0.97 (95% CI 0.91–1.00) and a negative predictive value of 0.97 (0.92–1.00) for LC. Discussion/Conclusions: The prevalence of alternative somatic and mental diseases in pediatric patients with suspected LC is high. The range of underlying diseases is wide, including chronic and potentially life-threatening conditions. Neurological and respiratory symptom clusters may help to identify patients that are unlikely to be suffering from LC.